Havencrest Healthcare Partners, L.P. - Oct 13, 2022 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
10%+ Owner
Signature
/s/ Havencrest Healthcare Partners, L.P., by Kyle Seco, as attorney-in-fact
Stock symbol
TOI
Transactions as of
Oct 13, 2022
Transactions value $
-$200,121
Form type
4
Date filed
10/17/2022, 09:30 PM
Previous filing
Oct 12, 2022
Next filing
Oct 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common stock Sale -$118K -25.2K -0.17% $4.67 14.4M Oct 13, 2022 See footnote F1, F4
transaction TOI Common stock Sale -$44.5K -9.8K -0.07% $4.54 14.4M Oct 14, 2022 See footnote F2, F4
transaction TOI Common stock Sale -$37.9K -8.25K -0.06% $4.60 14.4M Oct 17, 2022 See footnote F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.50 to $4.77, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.22 to $4.77, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.38 to $4.74, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
F4 TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein.